Sky Century Investment (SKYI) EBITDA Margin (QoQ) (2025 - 2026)
Sky Century Investment (SKYI) EBITDA Margin (QoQ) (2025 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.18 Bn | 43.22 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.96 Bn | 40.30 Bn | 2.15 Bn |
| 3 | Zoetis | 32.59 Bn | 30.92 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.33 Bn | 19.67 Bn | 683.80 Mn |
| 6 | Viatris | 18.90 Bn | 18.01 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.59 Bn | 15.20 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.95 Bn | 11.42 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.15 Bn | 9.98 Bn | - |
| 10 | Sky Century Investment | 393,547.71 | 393,283.71 | 26,045.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -2,499.00 |
| Feb 28, 2026 | 22,816.00 |
| Nov 30, 2025 | -10,049.00 |
| Aug 31, 2025 | -7,172.00 |
| May 31, 2025 | 14,680.00 |